PHARMAVIT ApS: Financial statements 2023
CVR: 29316775
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMAVIT ApS (CVR 29316775) has filed annual accounts for 2023. In 2023, the company reported a gross profit of EUR 215,697 and a net result of EUR 3,356,623 compared with EUR 707,851 the year before. That is a decrease of 81.3% compared with the year before. Equity in the 2023 report amounted to EUR 396,336. The solvency ratio was 82.2%.
- Gross Profit
- EUR 215,697
- Profit/Loss
- EUR 3,356,623
- Equity
- EUR 396,336
- Total Assets
- EUR 482,221
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 216 t. EUR | 3.4 mio. EUR | 396 t. EUR | 0 |
| 2022 | - | 1.2 mio. EUR | 708 t. EUR | 2.6 mio. EUR | 0 |
| 2021 | - | 889 t. EUR | 509 t. EUR | 1.9 mio. EUR | 1 |
| 2020 | - | 766 t. EUR | 500 t. EUR | 1.4 mio. EUR | 1 |
| 2019 | - | 464 t. EUR | 126 t. EUR | 924 t. EUR | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMAVIT ApS has published its annual report for 2022. Gross profit came to DKK 1,154,791, and the net result was DKK 707,851.
As of January 1, 2023, Wichert van Oene has stepped down as director of PHARMAVIT ApS.
About PHARMAVIT ApS
PHARMAVIT ApS was a Danish company of the type Anpartsselskab based in Helsinge, founded in 2006. The company was registered under the industry Engroshandel med andre fødevarer. The company was previously named ApS KBUS 17 NR. 4736. The company has 1 employee (2018). In 2024, the company reported a gross profit of EUR -11,114 and a net result of EUR -1,886 compared with EUR 3,356,623 the year before. Equity in the 2024 report amounted to EUR 394,450.